Company Filing History:
Years Active: 2023
Title: Innovations in Radiotherapy: The Contributions of Matthew John Harris
Introduction
Matthew John Harris is a notable inventor based in Hunters Hill, Australia. He has made significant contributions to the field of radiotherapy and diagnostic imaging through his innovative work. His expertise and dedication have led to the development of advanced formulations that enhance cancer treatment and diagnosis.
Latest Patents
Harris holds a patent for "Formulations and kits for radiotherapy and diagnostic imaging." This patent discloses aqueous formulations and kits of radiopharmaceutical compounds that are protected from radiolysis with stabilizers such as L-methionine and gentisic acid. The compounds are based on sarcophagine ligands coordinated to a radioisotope, such as 64-copper, and linked to a tetrazine group for reaction with tumor-targeting antibodies. These formulations are designed for use in radioimaging, diagnosing, and treating cancer.
Career Highlights
Harris is currently associated with Clarity Pharmaceuticals Ltd, where he continues to push the boundaries of medical technology. His work focuses on creating innovative solutions that improve patient outcomes in cancer treatment. His dedication to research and development has positioned him as a key figure in the field.
Collaborations
Harris collaborates with Sean Lumb, leveraging their combined expertise to advance their projects in radiopharmaceuticals. Their partnership exemplifies the importance of teamwork in driving innovation in healthcare.
Conclusion
Matthew John Harris's contributions to radiotherapy and diagnostic imaging are invaluable. His innovative formulations and commitment to improving cancer treatment highlight the critical role of inventors in advancing medical science.